Suven Life Sciences is a sure-shot tonic for profit
Scrip is at Rs 179, taken a massive and good volume + price breakout on Monday 3rd April 2017.
After complete bottoming out, scrip has taken firm support on 200W EMA between Feb 2016 to March 2017 and is now promising to break out decisively upwards.
Once it crosses 186~187, the momentum will be good.
Fundamentally, the balance sheet is sound, debt free and growing.
Expect price to double within a year.
Buy with a stoploss of Rs 168~161.
After complete bottoming out, scrip has taken firm support on 200W EMA between Feb 2016 to March 2017 and is now promising to break out decisively upwards.
Once it crosses 186~187, the momentum will be good.
Fundamentally, the balance sheet is sound, debt free and growing.
Expect price to double within a year.
Buy with a stoploss of Rs 168~161.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.